huperzine A
Selected indexed studies
- Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease. (Molecules, 2021) [PMID:34770940]
- Huperzine A. (Drugs R D, 2004) [PMID:14725492]
- Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease. (IUBMB Life, 2022) [PMID:35384262]
_Worker-drafted node — pending editorial review._
Connections
huperzine A protects against
huperzine A helps
Sources
- Huperzine A. (2004) pubmed
- Huperzine A for vascular dementia. (2009) pubmed
- Delineating biosynthesis of Huperzine A, A plant-derived medicine for the treatment of Alzheimer's disease. (2022) pubmed
- Role of huperzine a in the treatment of Alzheimer's disease. (2009) pubmed
- Huperzine A for Alzheimer's disease. (2008) pubmed
- Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease. (2022) pubmed
- Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease. (2021) pubmed
- Huperzine A targets Apolipoprotein E: A potential therapeutic drug for diabetic nephropathy based on omics analysis. (2024) pubmed
- Huperzine A. (2000) pubmed
- Huperzine A attenuates epileptic seizures via enhancing dCA1-projecting septal cholinergic transmission. (2025) pubmed